期刊文献+

胃癌组织中P16蛋白的异常表达与临床病理学意义 被引量:2

Abnormal Expression of P16 Protein in Gastric Carcinoma Tissues and Clinicopathological Significance
原文传递
导出
摘要 目的:通过研究P16蛋白表达与胃癌发生及胃癌临床病理因素的关系,以探讨检测P16蛋白在胃癌诊断及判断胃癌恶性程度、估计预后和指导临床治疗的临床病理学意义。方法:采用免疫组化S-P法,检测100例胃癌与20例正常胃黏膜组织中P16蛋白表达情况。结果:P16蛋白在胃癌中表达率(36.0%)明显低于正常胃黏膜组织(85.0%)(P<0.01);P16蛋白表达与肉眼类型、分化程度、浸润深度、淋巴结转移,TNM分期有关(P<0.05);P16蛋白表达与患者性别、年龄、原发灶部位无关(P>0.05)。结论:检测P16蛋白的表达对辅助胃癌的诊断有很高的价值,并可作为判断胃癌恶性程度、估计预后和指导临床治疗的临床病理参考指标。 Objective: To study the relations between the expression of P16 and the genesis of gastric carcinoma and the clinico-pathological characteristics of gastric carcinoma, and to investigate the clinicopathological significance of detection P16 on diagnosis of gastric carcinoma, degree of malignant, prognostic appreciation and clinical treatment. Methods: Expressions of P16 were examined by S-P immunohistochemical staining in 20 cases of normal gastric mucosas and 100 cases of gastric carcinoma. Results: The positive rate of P16 expression in gastric carcinoma was 36.0%, lower than that in nomal gastric mucosas (85.0%)( P 〈0.01); it is related to the differ- entiation, invasion, metastasis by lymphatics, and staging of TNM (P 〈0.05), but has nothing to do with sex, age, and situs of affection (P〉0.05). Conclusions: The detection of P16 is highly valued to diagnose gastric carcinoma and to evaluate the degree of malignant, prognostic appreciation and clinical treatment on gastric carcinoma.
出处 《现代生物医学进展》 CAS 2009年第2期292-294,314,共4页 Progress in Modern Biomedicine
基金 安徽省教育厅自然科学研究重点项目(编号:2006KJ100A)
关键词 胃癌 P16蛋白 免疫组织化学 Gastric carcinoma P16 protein Immunohistochemistry
  • 相关文献

参考文献5

二级参考文献59

  • 1Xiu-Sheng He Qi Su Zhu-Chu Chen Xiu-Tao He Zhi-Feng Long Hui Ling Liang-Run Zhang Oncology Institute,Nanhua University,Hengyang 421001,Hunan Province,ChinaOncology Institute,Center South University,Changsha 410078,Hunan Province,China Department of Gastroenterology,First People’s Hospital of Changde City,Changde 415003,Hunan Province,China.Expression,deleton and mnutation of ρ16 gene in human gastric cancer[J].World Journal of Gastroenterology,2001,7(4):515-521. 被引量:40
  • 2吕有勇,高崇峰,崔建涛,孙梅程,金泉.胃癌中MTS1/p16基因缺失及表达异常的研究[J].中华肿瘤杂志,1996,18(3):189-191. 被引量:88
  • 3Morsaki T, Uchiyama A, Yuzuki D, et al. Interleukin 4 regulates G1 cell cycle progression in gastric carcinoma cells [J]. Cancer Res, 1994,54(4):1113-1118.
  • 4Bartkova J, Lukas J, Muller H, et al. Cyclin D1 protein expression and function in human breast cancer [J]. Int J Cancer, 1994,57 (3) : 353-361.
  • 5Akama Y, Yasui WI,Kuniyas HI, et al. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines [J]. Jpn J Cancer Res, 1996,87(8) :824-830.
  • 6Igaki H, Sasaki H, Kishi T, et al. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines [J].Biochem Biophys Res Commun, 1994,203(2) : 1090-1095.
  • 7Shiohara M, E1-Deiry WS, Wada M, et al. Absence of WAF1 mutations in a variety of human malignancies [J]. Blood,1994,84( 11 ) :3781-3784.
  • 8Slebos R J, Baas IO, Clement M, et al. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21^WAF1/Cip1 in colorectal carcinoma[J]. Br J Cancer, 1996,74(2):165-171.
  • 9Noda H, Maehara Y, Irie K, et al. Growth pattern and expressions of cell cycle regulator proteins p53 and p21^WAF1/CIP1 in early gastric carcinoma [J]. Cancer, 2001,92(7):1828-1835.
  • 10Liu XP, Tsushimi K, Tsushimi M, et al. Expression of P21^^WAF1/CIP1 and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis [J].Cancer Lett, 2001,170(2) : 183-189.

共引文献40

同被引文献18

  • 1李士军,袁宏,刘新元.p16基因甲基化对胃癌的早期诊断[J].中国误诊学杂志,2005,5(4):607-609. 被引量:1
  • 2李静,李辉,李舒,郑学峰,李潮.p^(16)、bcl-2基因蛋白在胃癌和癌前病变的表达及意义[J].锦州医学院学报,2005,26(2):1-4. 被引量:3
  • 3Hofmann M,Stoss O, Shi D, et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study [ J ]. Histopathology ,2008,52 ( 7 ) :797 - 805.
  • 4Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4 [J]. Nature, 1993,336(16) :704 - 707.
  • 5Kamb A, Gruis N, Weaver-Feldaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types [ J ]. Science, 1994,264 ( 5157 ) :436 - 440.
  • 6Press MF, Finn RS, Cameron D, et al. HER-2 genc amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression,and lapatinib efficacy in women with metastatic breast cancer[ J]. Clin Cancer Res ,2008,14 ( 23 ) :7861 - 7870.
  • 7Andreas H, Marx MD, Lars Tharun, et al. HER-2 amplification is highly homogenous in gastric cancer [ J ]. Human Pathology, 2009,40 ( 6 ) : 769 - 777.
  • 8William HD, Fry LK, Colleen S, et al. Mechanisms of ErbB receptor negative regulation and relevance in cancer[ J]. Exp Cell Res,2009,315 (4) :697 - 706.
  • 9Barros JD,Leitao D, Afonso L, et al. Association of ERBB2 gene status with histopathological parameters and disease specific survival in gastric carcinoma patients [ J ]. Br J Cancer, 2009,100 (3) :487 -493.
  • 10Sun YK, Hwang PK, Yu JK,et al. Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin [ J ]. Int J Concol, 2008,32 ( 1 ) : 89 - 95.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部